Delivery Order SPE2DR25D2104-SPE2DR26F3UNX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $1,932.48. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Carvedilol is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $4,928.98. This contract represents a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,111.50 for Carvedilol ER 40 mg capsules (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing...
- The Defense Logistics Agency awarded a delivery order valued at $7,968.71 to Amerisourcebergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker used to treat cardiovascular conditions including hypertension and heart...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) valued at $3,322.66. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the primary pharmaceutical distributor. The order is scheduled for completion by September 19, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on October 20, 2025, with a ceiling value of $1,378.78 and an ultimate completion date of October 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. Performance will take place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on December 2, 2025, with a ceiling value of $1,413.96 and an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $2,156.18. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 13, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $2,185.41 and an ultimate completion date of September 23, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3UNXDelivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 28, 2026, for Carvedilol ER 40 mg capsules in quantities of 30 units. The contract carries a ceiling value of $8,735.99 and is scheduled for completion by January 29, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office and primary distribution operations. This delivery order represents a task order under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999 and extends through December 2026. The parent IDC serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Carvedilol, a beta-blocker commonly used to treat heart failure and hypertension, falls within the broad therapeutic categories covered under this framework agreement. The delivery order demonstrates Amerisourcebergen's continued role as a critical pharmaceutical vendor for federal military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 1/27/26 |